German Lymphoma Alliance registry
Recruiting
- Conditions
- C83.3Diffuse large B-cell lymphoma
- Registration Number
- DRKS00033272
- Lead Sponsor
- German Lymphoma Alliance (GLA) e.V.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
1. Malignant lymphoma (except for Hodgkin’s disease (MH) without concomitant HIV infection, multiple myeloma (MM) and chronic lymphocytic leukemia (CLL)) or related lymphoproliferative disease e.g. Castleman’s disease
2. Informed consent
Exclusion Criteria
There are no exclusion criteria.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nderstand the course of disease of different malignant lymphoma entities. Understand the results and impact of specific treatment methods. <br>
- Secondary Outcome Measures
Name Time Method •Understand scope of responses to sequentially applied treatments<br>•Collect real world data on treatments used<br>•Collect real world data on progression free survival <br>•Collect real world data on overall survival<br>•Collect real world data on healthcare resource utilization (project-specific)<br>•Develop prediction model for selection of drugs<br>•Analysis of treatment schedule algorithms<br>•Long-term follow-up of clinical trials<br>•Analyze treatment specific adverse events (project-specific)<br>•Evaluation of prognostic scoring system in the population of subpopulations<br>•Evaluation of impact of comorbidity scores on outcome<br>•Evaluation of Quality of Life (project-specific)<br>